TY - JOUR
T1 - Lactone-rich fraction from Vernonia blumeoides
T2 - Antitrypanosomal activity and alleviation of the parasite-induced anemia and organ damage
AU - Ibrahim, M. A.
AU - Aliyu, A. B.
AU - Abdullahi, H.
AU - Solomon, T.
AU - Toko, E.
AU - Garba, A.
AU - Bashir, M.
AU - Habila, N.
PY - 2013/10
Y1 - 2013/10
N2 - The anti-Trypanosoma brucei brucei activity in vitro and in vivo of a lactone-rich fraction of Vernonia blumeoides leaves (VBLF) and its potential in alleviating trypanosome-induced anemia and organ damage were investigated. Gas chromatography-mass spectrometry (GC-MS) analysis of VBLF revealed the presence of a number of lactone-containing compounds. In an in vitro study, VBLF showed concentration-dependent activity and was further used to treat T. brucei brucei-infected rats. The VBLF treatments, especially at 300 mg/kg body weight (BW), significantly (P < 0.05) kept the parasites reduced during the entire experimental period compared with the infected untreated group. At the end of the experiment, the trypanosome-induced anemia and hepatic damage were significantly (P < 0.05) alleviated in all the VBLF treatment groups, but renal damage was only prevented in the 200 and 300 mg/kg BW treatment groups. Furthermore, the trypanosome-induced increase in the relative weights of liver, spleen and kidney were significantly (P < 0.05) alleviated by the 300 mg/kg BW VBLF treatment. It was concluded that orally administered VBLF, especially at 300 mg/kg BW, possessed antitrypanosomal activity and could alleviate parasite-induced anemia and organ damage.
AB - The anti-Trypanosoma brucei brucei activity in vitro and in vivo of a lactone-rich fraction of Vernonia blumeoides leaves (VBLF) and its potential in alleviating trypanosome-induced anemia and organ damage were investigated. Gas chromatography-mass spectrometry (GC-MS) analysis of VBLF revealed the presence of a number of lactone-containing compounds. In an in vitro study, VBLF showed concentration-dependent activity and was further used to treat T. brucei brucei-infected rats. The VBLF treatments, especially at 300 mg/kg body weight (BW), significantly (P < 0.05) kept the parasites reduced during the entire experimental period compared with the infected untreated group. At the end of the experiment, the trypanosome-induced anemia and hepatic damage were significantly (P < 0.05) alleviated in all the VBLF treatment groups, but renal damage was only prevented in the 200 and 300 mg/kg BW treatment groups. Furthermore, the trypanosome-induced increase in the relative weights of liver, spleen and kidney were significantly (P < 0.05) alleviated by the 300 mg/kg BW VBLF treatment. It was concluded that orally administered VBLF, especially at 300 mg/kg BW, possessed antitrypanosomal activity and could alleviate parasite-induced anemia and organ damage.
KW - Anemia
KW - Antitrypanosomal activity
KW - Lactones
KW - Organ damage
KW - Vernonia blumeoides
UR - https://www.scopus.com/pages/publications/84884202505
U2 - 10.1007/s11418-012-0737-9
DO - 10.1007/s11418-012-0737-9
M3 - Article
C2 - 23292278
AN - SCOPUS:84884202505
SN - 1340-3443
VL - 67
SP - 750
EP - 757
JO - Journal of Natural Medicines
JF - Journal of Natural Medicines
IS - 4
ER -